Large business executives—those from companies with 1,000 or more employees—face an increasingly complex risk landscape with 93% reporting similar or higher stress than last year. Learn how they are navigating mounting pressures.
Geopolitical shocks, federal policy whiplash and surging demand from data centers are accelerating exposures for directors and officers in the energy sector. Choosing the right risk transfer partner should be top of mind for many.
As actuaries develop more sophisticated tools to evaluate risk, legislators are increasingly focused on what constitutes fair insurance pricing. Here’s how the industry is working to find common ground.
As market capacity and pricing fluctuate, organizations should reassess risk strategies. AXA XL’s new alternative risk solutions center of excellence helps clients build resilient approaches.
The liability insurance market faces challenges, with nuclear verdicts skyrocketing and premiums climbing. Litigation is unlikely to improve, making robust risk management essential.
As consolidation reshapes the healthcare landscape, buyers and sellers face unique insurance risks that standard policies were never designed to address.
As artificial intelligence reshapes the insurance landscape, insurers that fail to account for change management, data integrity, and regulatory oversight risk costly missteps.
Musculoskeletal disorders plague American workers, but new diagnostic approaches give safety leaders practical tools to identify and address ergonomic risks before injuries occur.
As AI reshapes the claims landscape, insurance professionals reveal how human expertise and relationships remain central to protecting client interests.
As U.S.-based organizations expand globally, property risks are becoming more interconnected — requiring a coordinated approach to managing exposures across borders.
As climate effects and non-peak perils challenge traditional diversification strategies, property insurers need a comprehensive approach to accumulation risk that goes far beyond standard modeling.
Life science companies face unique D&O exposures at every stage of development — but disciplined practices and specialized insurance support can help mitigate the risk.
As acute mental health cases surge and legal exposure grows, carriers are facing unprecedented challenges in claims handling and underwriting decisions.